Pfizer Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $32.58B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $2.71B | 8.3% |
| Other Investing | $19.84B | 60.9% |
| Other Financing | $8.82B | 27.1% |
| Other | $1.06B | 3.2% |
| Net Cash Flow | $159.0M | 0.5% |